The Biology of the Interferon System 1986 1987
DOI: 10.1007/978-94-009-3543-3_41
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms of Anticancer Action of Interferons on Human Tumour Xenografts in Nude Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

1989
1989
1995
1995

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 8 publications
0
6
0
Order By: Relevance
“…The nude mouse model is suitable for studies of the effects of human IFNs on human xenografts since IFNs are largely species specific (Uenishi et al 1983;Heston et al 1984;Balkwill et al 1986). Antitumor effects can be regarded as the result of a direct effect of the human IF" on the human tumor cells.…”
Section: The Nude Mousementioning
confidence: 99%
See 2 more Smart Citations
“…The nude mouse model is suitable for studies of the effects of human IFNs on human xenografts since IFNs are largely species specific (Uenishi et al 1983;Heston et al 1984;Balkwill et al 1986). Antitumor effects can be regarded as the result of a direct effect of the human IF" on the human tumor cells.…”
Section: The Nude Mousementioning
confidence: 99%
“…Human IFN does not induce IFN dependent enzymes in nude mice nor stimulate natural killer cells (Balkwill et al 1982;Uenishi et al 1983;Heston et al 1984;Balkwill et al 1986). However, murine IFN can inhibit the growth of human xenografts in immunodeficient mouse (Gresser et al 1972;Balkwill et al 1986). This antitumor effect is considered to reflect a disturbance of human tumor cell and mouse stromal cell interactions.…”
Section: Commentsmentioning
confidence: 99%
See 1 more Smart Citation
“…Preliminary results indicate a positive efficacy of hu man IFN-y in renal carcinoma xenografts [46], whereas human breast carcinomas showed very little sensitivity to human IFN-y [47], It is hoped that stu dies of this type will yield more information on the mechanisms of action of IFNs, resulting in more ratio nal approaches to the design of clinical trials. It will be particularly interesting to see whether IFN-y, with its much broader spectrum of immunomodulatory activities, differs in its mode of action from IFN-a or IFN-p.…”
Section: Antitumour Activity In Vivomentioning
confidence: 99%
“…1986;Balkwill et al, 1987). Later, Thom et al (1992) reported improvement of the anti-tumour effect and higher cure rate of MCA sarcomas treated with paralesional administration of TNF-a.…”
mentioning
confidence: 99%